EP0466174A1 — Novel physiologically active porcine peptide (CNP-53)
Assigned to Individual · Expires 1992-01-15 · 34y expired
What this patent protects
A peptide composed of 53 amino acid residues represented by the following amino acid sequence: and derivatives thereof represented by the following amino acid sequence: wherein X is as shown in the specification, are disclosed. These polypeptides are novel and have na…
USPTO Abstract
A peptide composed of 53 amino acid residues represented by the following amino acid sequence: and derivatives thereof represented by the following amino acid sequence: wherein X is as shown in the specification, are disclosed. These polypeptides are novel and have natriuretic and hypotensive actions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.